Pemirolast: Difference between revisions
Jump to navigation
Jump to search
(Created page with "{{Drugbox | Verifiedfields = changed | verifiedrevid = 408530718 | IUPAC_name = 9-methyl-3-(1''H''-tetrazol-5-yl)-4''H''-pyrido[1,2-''a'']pyrimidin-4-one | image = Pemirolast....") |
No edit summary |
||
| Line 67: | Line 67: | ||
*{{cite web | author = Mitsubishi Tanabe Pharma Corporation | year = 2007 | url = http://www.e-search.ne.jp/~jpr/PDF/MITSUB32.PDF | title = ALEGYSAL (English) | accessdate = 2008-09-02}} | *{{cite web | author = Mitsubishi Tanabe Pharma Corporation | year = 2007 | url = http://www.e-search.ne.jp/~jpr/PDF/MITSUB32.PDF | title = ALEGYSAL (English) | accessdate = 2008-09-02}} | ||
*{{cite web | author = VISTAKON Pharmaceuticals, LLC | year = 2005 | url = http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?id=3230 | title = ALAMAST (pemirolast potassium opthalmic solution) 0.1% | accessdate = 2008-09-02}} | *{{cite web | author = VISTAKON Pharmaceuticals, LLC | year = 2005 | url = http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?id=3230 | title = ALAMAST (pemirolast potassium opthalmic solution) 0.1% | accessdate = 2008-09-02}} | ||
| Line 77: | Line 74: | ||
[[Category:Lactams]] | [[Category:Lactams]] | ||
[[Category:Pyridopyrimidines]] | [[Category:Pyridopyrimidines]] | ||
Revision as of 21:08, 29 June 2012
 | |
| Clinical data | |
|---|---|
| Trade names | Alamast |
| AHFS/Drugs.com | Monograph |
| Pregnancy category |
|
| Routes of administration | Oral, ophthalmic |
| ATC code |
|
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEMBL | |
| E number | {{#property:P628}} |
| ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
| Chemical and physical data | |
| Formula | C10H8N6O |
| Molar mass | 228.21 g/mol |
| 3D model (JSmol) | |
| |
  (what is this?) (verify) | |
Overview
Pemirolast (INN) is an anti-allergic drug. It is marketed under the tradenames Alegysal and Alamast.
It has also been studied for the treatment of asthma.
References
- Tinkelman DG, Berkowitz RB (1991). "A pilot study of pemirolast in patients with seasonal allergic rhinitis". Ann Allergy. 66 (2): 162–5. PMID 1994787. Unknown parameter
|month=ignored (help) - Kawashima T, Iwamoto I, Nakagawa N, Tomioka H, Yoshida S (1994). "Inhibitory effect of pemirolast, a novel antiallergic drug, on leukotriene C4 and granule protein release from human eosinophils". Int. Arch. Allergy Immunol. 103 (4): 405–9. doi:10.1159/000236662. PMID 8130655.
- Abelson MB, Berdy GJ, Mundorf T, Amdahl LD, Graves AL (2002). "Pemirolast potassium 0.1% ophthalmic solution is an effective treatment for allergic conjunctivitis: a pooled analysis of two prospective, randomized, double-masked, placebo-controlled, phase III studies". J Ocul Pharmacol Ther. 18 (5): 475–88. doi:10.1089/10807680260362759. PMID 12419098. Unknown parameter
|month=ignored (help) - Kemp JP, Bernstein IL, Bierman CW; et al. (1992). "Pemirolast, a new oral nonbronchodilator drug for chronic asthma". Ann Allergy. 68 (6): 488–91. PMID 1610024. Unknown parameter
|month=ignored (help)
External links
- Mitsubishi Tanabe Pharma Corporation (2007). "ALEGYSAL (English)" (PDF). Retrieved 2008-09-02.
- VISTAKON Pharmaceuticals, LLC (2005). "ALAMAST (pemirolast potassium opthalmic solution) 0.1%". Retrieved 2008-09-02.
Categories:
- Pages with script errors
- Template:drugs.com link with non-standard subpage
- Drugs not assigned an ATC code
- Drugs with non-standard legal status
- Articles with changed ChemSpider identifier
- Articles with changed EBI identifier
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Chemical pages without DrugBank identifier
- Articles without InChI source
- Drugboxes which contain changes to verified fields
- Pages with citations using unsupported parameters
- CS1 maint: Multiple names: authors list
- CS1 maint: Explicit use of et al.
- H1 receptor antagonists
- Tetrazoles
- Lactams
- Pyridopyrimidines